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Babesia gibsoni is a haemoprotozoan parasite of emerging global importance. The 
clinical presentation of babesial infections is diverse and the systemic inflammatory response 
induced by infection is considered to be a major feature of the pathophysiology of canine 
babesiosis. An experimental case-controlled longitudinal study was conducted to assess the 
clinical, haematological, cytokine and acute phase protein changes that occur during 
experimental B. gibsoni infection of beagle puppies. Infected dogs became transiently pyrexic 
and anaemic, intermittently neutropenic and transiently, but profoundly, thrombocytopenic, 
although this had no apparent adverse clinical effect. Experimental B. gibsoni infection also 
induced an acute phase response, characterised by a marked increase in the concentration of 
C-reactive protein, which was delayed in onset following infection but preceded the detection 
of peripheral parasitaemia. Experimental B. gibsoni infection was also associated with marked 
increases in the concentration of multiple cytokines which were also delayed in onset 
following infection and occurred subsequent to the detection of peripheral parasitaemia and 
the acute phase response. This study furthers our understanding of the immune response that 
occurs during babesial infections and the role that sys emic inflammation plays in the 
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Babesia gibsoni is a vector-borne haemoprotozoan parasite of emerging global 
importance with infections documented throughout Asia, Australia, Africa, North and South 
America and Europe (Irwin, 2009). Infection occurs following the bite of an infected ixodid 
tick from the genus Haemaphysalis and, possibly, the genus Rhipicephalus (Irwin, 2010). 
Sporozoite transmission into the bloodstream of the canine host results in erythrocyte 
invasion, intra-erythrocytic multiplication, and subsequent erythrocyte lysis, releasing more 
parasites into the bloodstream to infect additional erythrocytes or new ixodid vectors (Irwin, 
2010). Non-vectorial routes of transmission have also been documented for B. gibsoni 
including transplacental transmission and transmission by blood transfusions or fighting 
(Stegeman et al., 2003; Fukumoto et al., 2005; Jefferi s et al., 2007a). 
The clinical presentation of canine babesiosis can vary widely from subclinical to 
fulminant disease resulting in multiple organ failure and death (Irwin, 2010). The severity of 
the disease is primarily determined by the species of Babesia parasite involved, with B. 
gibsoni considered intermediate in its pathogenicity (Schoeman, 2009). However, host 
factors, including age and immune response, can also play a role in determining the severity 
of the disease (Oduye and Dipeolu, 1976; Lewis et al., 1995; Jacobson, 2006). Natural and 
experimental B. gibsoni infections are typically characterised by pyrexia, lethargy, anaemia, 
thrombocytopenia, icterus and splenomegaly (Jefferis et al., 2007b; Schoeman, 2009).  
Infection with babesial parasites induces a systemic inflammatory response in the host 
and this is considered to be a major feature of the pathophysiology of canine babesiosis which 
contributes to its diverse clinical manifestations (Welzl et al., 2001; Matijatko et al., 2007; 














development of systemic inflammation and are responible for mediating and regulating all 
aspects of the immune response to infection (Borghetti et al., 2009; Lewis et al., 2012). 
However, while important for host defence, excessive production and release of these 
immunoregulatory mediators can prove deleterious to the host, initiating widespread tissue 
injury and organ damage (Borghetti et al., 2009; Lewis et al., 2012). Longitudinal kinetic 
profiling of a broad range of cytokine alterations that occur during an infection can be useful 
to expand our understanding of the immunopathogenesis of infectious diseases and host-
adaptive humoral and cell-mediated immune responses to infection, as well as potentially 
allowing the identification of future diagnostic markers and therapeutic interventions. 
The immunopathogenesis of canine babesiosis is poorly understood at a cellular level. 
To date, the only cytokine investigated in canine babesiosis is tumour necrosis factor alpha 
(TNF-α) which was reported in a single study that assessed TNF-α concentrations in dogs 
naturally infected with B. rossi at the time of presentation to a veterinary hospital with clinical 
signs of babesiosis (Vaughan-Scott, 2001). In this study higher TNF-α concentrations were 
found in dogs with higher peripheral parasitaemias and more severe disease, although no 
association between TNF-α concentration and mortality was identified. The kinet cs that 
occur in other cytokines in canine babesiosis have yet to be characterised.  
In response to inflammatory cytokine secretion, increased production of positive acute 
phase proteins, such as C-reactive protein (CRP), occurs as part of the innate immune 
response to infection (Murata et al., 2004; Ceron et al., 2005). In dogs, CRP is regarded as a 
major acute phase protein and can be used as a sensitive biomarker to quantify systemic 
inflammation (Murata et al., 2004; Ceron et al., 2005). An acute phase response to natural B. 
rossi infections, and both natural and experimental B. canis infections, has been documented 














2009). Increased concentrations of CRP were identifi d n dogs naturally infected with B. 
rossi and B. canis at the time of presentation to a veterinary hospital with clinical signs of 
canine babesiosis and persistently increased CRP concentrations were noted in dogs within 2-
4 days of experimental infection with B. canis (Ulutas et al., 2005; Matijatko et al., 2007; 
Koster et al., 2009; Schetters et al., 2009). However, no association between CRP 
concentration and disease outcome was identified. The acute phase response to B. gibsoni 
infection has yet to be characterised. 
The aim of this longitudinal study was to investigae the cytokine kinetics together 
with the clinical, haematological and acute phase protein changes that occur during 
experimental B. gibsoni infection of beagle puppies. 
 
2. Materials and methods 
 
2.1. Experimental animals 
 
Four intact five month old beagle litter-mates were us d in an experiment performed 
as part of the production of microscope slides used commercially in an indirect fluorescent 
antibody test (IFAT) for the diagnosis of B. gibsoni infections. All four dogs were confirmed 
to be free of B. gibsoni infection by polymerase chain reaction (PCR) and IFAT (Vetpath 
Laboratory Services (VLS), Australia) prior to the start of the experiment. All four dogs were 
housed together in the Animal House facility at Murdoch University for the duration of the 
experiment and managed under identical conditions. The experiment was started after an 
acclimatisation period of two weeks. All four dogs were fed a commercial dry dog food 














study was approved by the Murdoch University Animal Ethics Committee (Permit Number: 
R2442/11). 
 
2.2. Experimental B. gibsoni infection 
 
Blood was collected from an American pit bull terri (red blood cell count 5.2 x 
1012/L; reference interval 5.5-8.5 x 1012/L) suspected to be infected with B. gibsoni. Parasites 
were not observed in erythrocytes on manual blood smear evaluation but infection was 
confirmed by nested PCR amplification of a partial fr gment of the 18S rRNA gene of B. 
gibsoni as described previously (Jefferies et al., 2007a). Dogs 1 and 2 were infected with B. 
gibsoni (Day 0) via intravenous injection of 10ml of ethylenediaminetetraacetic acid (EDTA) 
anti-coagulated whole blood collected from the American pit bull terrier. Dogs 3 and 4 were 
used as situational controls. The experiment was terminated on Day 23 to allow production of 
the IFAT slides. Infected dogs were humanely euthanased by barbiturate overdose on Day 24. 
 
2.3. Clinical evaluation 
 
A complete physical examination was performed on Days 0-23 inclusive in all dogs. 
Heart rate, respiratory rate and body temperature wer  recorded. Pyrexia was defined as a 
body temperature greater than 39.3°C.  
 















Blood (1.3-9.3ml) was collected from each dog every da  by jugular venepuncture and 
placed into potassium EDTA (Sarstedt, Australia) (1.3ml), lithium heparin (Greiner Bio-One, 
United States of America) (4ml) and serum (Greiner Bio-One, United States of America) 
(4ml) tubes. Samples were centrifuged within 2 hours of collection at 2000G and serum or 
plasma supernatant transferred into plain tubes (Sarstedt, Australia) (1.5ml aliquots), frozen 
and stored at -20°C until analysis.  
 
2.5. Haematological analysis 
 
A complete blood count was performed to assess erythrocyte, leucocyte and platelet 
numbers using EDTA-anticoagulated whole blood on Days 0-22 inclusive in infected dogs 
and Days 0, 1, 3, 5, 6 and 8-22 inclusive in control dogs. Samples were analysed on the day of 
collection at VLS using the CELL-DYN 3700 automated haematology analyser (Abbott 
Diagnostics, United States of America). Manual blood smear assessment was performed on 
each sample to manually enumerate platelet numbers, examine erythrocyte and leucocyte 
morphology and determine differential leucocyte counts. Erythrocytes were specifically 
evaluated for the presence of intra-erythrocytic parasites and an estimation of the magnitude 
of peripheral parasitaemia present (expressed as the percentage of the total number of red 
blood cells that contained parasites) was recorded. Anaemia was defined as an absolute red 
blood cell count less than 3.7 x 1012/L, based upon age and breed specific reference intervals 
previously described for laboratory beagles (Harper et al., 2003). Leucopenia and neutropenia 
were defined as an absolute white blood cell count less than 6.0 x 109/L and an absolute 
neutrophil count less than 3.0 x 109/L respectively. A left shift was defined as a band 














less than 150 x 109/L. If platelet numbers were less than 150 x 109/L but manual smear 
assessment identified sufficient platelet clumping that platelet numbers were deemed adequate 
thrombocytopenia was not considered to be present. 
 
2.6. C-reactive protein measurement 
 
Plasma CRP concentrations were measured on Days 0, 3, 5, 6, 8, 9 and 11-22 
inclusive in all dogs. Samples were shipped on ice and analysed using an 
immunoturbidimetric CRP assay (Avacta Animal Health, United Kingdom) validated for use 
in dogs. Increased CRP concentrations were defined as those greater than 15mg/L, based upon 
age and breed specific reference intervals previously described for laboratory beagles 
(Kuribayashi et al., 2003). 
 
2.7. Cytokine measurement 
 
The serum concentrations of 13 cytokines (TNF-α, interferon-γ (IFN-γ), monocyte 
chemoattractant protein-1 (MCP-1), granulocyte-macrophage colony-stimulating factor (GM-
CSF), interleukin (IL)-2, IL-6, IL-7, IL-8, IL-10, IL-15, IL-18, interferon-γ-induced protein 
(IP-10) and keratinocyte-derived chemokine (KC-like)) were measured on Days 0, 1, 4, 7, 10, 
13, 15-20 inclusive and 23 in all dogs using a commercially available canine-specific 
multiplex cytokine immunoassay (MILLIPLEX MAP Canine Cytokine/Chemokine Magnetic 
Bead Panel CCYTOMAG-90K-PX13, Merck Millipore, United States of America). The 
selection of cytokines measured was determined by those available in the MILLIPLEX MAP 














according to the manufacturer’s instructions. Samples were analysed using a Bio-Plex 
MAGPIX Multiplex Reader (Bio-Rad, United States of America) equipped with a Luminex 
XMAP technology detection system. Data were evaluated using the Bio-Plex Manager 
software (Bio-Rad, United States of America). Seven-point standard curves, created from 
known concentrations of recombinant canine cytokines, were analysed using a five-parameter 
logistic regression curve-fitting method to determine the concentration of each cytokine. 
Intra-assay and inter-assay coefficients of variation stated by the manufacturer for all cytokine 
analytes were <5% and <17% respectively. The minimum detectable concentrations of the 13 
cytokines provided by the manufacturer were regarded as the detection limits in this study 
(TNF-α 6.1pg/ml; IFN-γ 13.6pg/ml; MCP-1 21pg/ml; GM-CSF 9.2pg/ml; IL-2 3.5pg/ml; IL-6 
3.7pg/ml; IL-7 7.5pg/ml; IL-8 21.7pg/ml; IL-10 8.5pg/ml; IL-15: 9.0pg/ml; IL-18 5.8pg/ml; 
IP-10 3.2pg/ml; KC-like 5.3pg/ml) and values below the detection limit were assigned a value 
equal to the minimum detectable concentration for the respective cytokine. As reference 
intervals have not been established in healthy dogsfor any of the 13 cytokines measured in 
this experiment all changes detected in the concentration of cytokines were described in 




3.1. Experimental infection 
 
 Babesia gibsoni infection was successfully established in Dogs 1 and 2. The 
peripheral parasitaemia of Dogs 1 and 2 throughout the experiment are shown in Figure 1. 














dogs. Peripheral parasitaemia increased in magnitude over the following week and by Day 22 
intra-erythrocytic parasites were observed in 5% of circulating erythrocytes in both dogs. 
Parasites were not detected in the circulating red blood cells of Dog 3 or 4 at any time.  
 
3.2. Clinical observations 
 
No abnormalities in heart or respiratory rate were noted in any dog at any time. 
Pyrexia developed in Dog 1 on Day 14 and in Dog 2 on Day 13 prior to the detection of 
peripheral parasitaemia. However, the pyrexia resolved in both dogs by Day 18 and did not 
reoccur despite further increases in the magnitude of the peripheral parasitaemia over the next 
week. No abnormalities in body temperature were documented in Dog 3 or 4 at any time. 
 
3.3. Haematological results 
 
The red blood cell counts of all four dogs throughout the experiment are shown in 
Figure 2. Both Dogs 1 and 2 developed a mild anaemi on Day 15 (Dog 1 red blood cell count 
3.1 x 1012/L; Dog 2 red blood cell count 3.7 x 1012/L) coincident with the onset of peripheral 
parasitaemia. However, this anaemia was transient and resolved in both infected dogs by Day 
17 despite further increases in the magnitude of the peripheral parasitaemia over the following 
week. Mild anisocytosis and polychromasia were noted in the erythron of all dogs throughout 
the experiment. However, a corrected reticulocyte count greater than 1.5% (maximum 2.9%) 
and more marked anisocytosis and polychromasia indicative of a regenerative response were 














The neutrophil counts of all four dogs throughout the experiment are shown in Figure 
3. Leucopenia and neutropenia developed in Dog 1 on Days 14-16 inclusive and Days 18-19 
inclusive. Dog 2 became leucopenic and neutropenic on Days 1, 5, 14-17 inclusive and 21. 
The nadir in the neutrophil count occurred in both dogs at about the same time that a 
peripheral parasitaemia was first detected (Dog 1 neutrophil count 1.8 x 109/L on Day 15; 
Dog 2 neutrophil count 2.0 x 109/L on Day 16). Toxic changes were noted in the neutrophils 
of both infected dogs intermittently during the periods of neutropenia but neither infected dog 
developed a left shift at any point. No abnormalities of lymphocyte, monocyte or eosinophil 
numbers were detected at any time in any dog.   
The platelet counts of all four dogs throughout the experiment are shown in Figure 4. 
Marked thrombocytopenia, which was absolute on some days, developed in Dog 1 between 
Days 14-18 inclusive and in Dog 2 between Days 14-16 inclusive. This thrombocytopenia 
developed prior to the detection of peripheral parasitaemia and resolved despite further 
increases in the magnitude of the peripheral parasit emia over the following week. 
No abnormalities in the erythron, leucon or thrombon of Dog 3 or 4 were detected. 
 
3.4. C-reactive protein results 
 
The CRP concentrations throughout the experiment are shown in Figure 5. The CRP 
concentration increased transiently in Dogs 1 and 2 on Day 3. The magnitude of this increase 
was mild (Dog 1 CRP concentration 20.86mg/L; Dog 2 CRP concentration 19.03mg/L). 
However, on Day 13, prior to the detection of peripheral parasitaemia, both infected dogs 
developed a marked increase in CRP concentration. This increase peaked on Day 15 (Dog 1 














onset of peripheral parasitaemia. Following this, the concentration of CRP gradually 
decreased but remained persistently mildly elevated in both infected dogs for the remainder of 
the experiment. No increase in the CRP concentration occurred at any time in Dog 3 or 4. 
 
3.5. Cytokine results 
 
The concentrations of TNF-α, MCP-1, GM-CSF, IL-2, IL-6, IL-7, IL-8, IL-10, IL-15, 
IL-18 and KC-like in all four dogs throughout the exp riment are shown in Figures 6-16. 
In Dog 1 the concentrations of TNF-α, GM-CSF, IL-2, IL-6 and IL-18 increased from 
Day 17 onwards with simultaneous peaks on Day 18 (TNF-α, GM-CSF, IL-2, IL-6 and IL-18 
concentrations 59pg/ml, 127pg/ml, 63pg/ml, 134pg/ml and 194pg/ml, respectively). 
Persistent, albeit less marked, increases in the concentration of all these cytokines were 
documented for the remainder of the experiment. The concentration of IL-7 increased on Day 
18 only (81pg/ml). 
 In Dog 2 the concentrations of TNF-α, IL-2, IL-7 and IL-18 increased markedly on 
Day 23 (TNF-α, IL-2, IL-7 and IL-18 concentrations 3527pg/ml, 1266 pg/ml, 18253pg/ml 
and 8533pg/ml, respectively). The concentration of IL-6 was initially increased prior to 
infection (75pg/ml on Day 0) before gradually decreasing to the minimum detectable 
concentration by Day 13. Mild increases in the concentration of IL-6 and GM-CSF were then 
noted on Days 15, 18 and 21 followed by marked increases on Day 23 (8473pg/ml and 
8860pg/ml respectively). 
The concentration of TNF-α, GM-CSF, IL-2, IL-6, IL-7 and IL-18 did not increase 
substantially above the minimum detectable concentration for the respective cytokine at any 














The concentration of IL-8 in Dogs 1, 3 and 4 ranged from 22-3133pg/ml throughout 
the experiment. In Dog 2 the IL-8 concentration increased markedly above this range between 
Days 16-20 inclusive with a peak on Day 20 (7056pg/ml). 
Increased IL-10 concentrations were noted on Days 13-16 inclusive and 23 in Dog 1 
with a peak on Day 15 (679pg/ml) and on Days 15 (140pg/ml) and 18 (133pg/ml) in Dog 2. 
The concentration of IL-10 did not increase above the minimum detectable concentration at 
any time in Dog 3 or 4. 
Increased IL-15 concentrations were noted from Day 17 onwards in Dog 1 with a peak 
on Day 18 (266pg/ml) and from Day 15 onwards in Dog 2 with a peak on Day 23 
(16463pg/ml). In Dog 3 the concentration of IL-15 increased on Day 1 (169pg/ml) and 
remained persistently elevated throughout the experiment while in Dog 4 no increases in the 
concentration of IL-15 above the minimum detectable concentration occurred at any time. 
The concentration of KC-like in infected dogs increas d markedly above the range of 
concentrations seen in control dogs throughout the experiment (125-884pg/ml) on Day 16 
only (Dog 1 KC-like concentration 2336pg/ml; Dog 2 KC-like concentration 1134pg/ml).  
No apparent difference in the MCP-1 concentration between infected and control dogs 
was noted throughout the experiment. The concentration of IFN-γ and IP-10 did not increase 




Experimental B. gibsoni infections were successfully established in Dogs 1 and 2 in 














parasitaemia in the dogs in this study was consistent with previously reported prepatent 
periods for experimental B. gibsoni infection (Meinkoth et al., 2002; Jefferies et al., 2007b).  
 A mild anaemia developed in both infected dogs in th s study coincident with the 
onset of peripheral parasitaemia. Anaemia is a well-documented finding in canine babesiosis 
with direct parasite-induced damage to erythrocytes resulting in haemolysis of infected red 
blood cells (Irwin, 2010). However, the anaemia in both dogs in this experiment was transient 
and resolved despite further increases in the magnitude of the peripheral parasitaemia. This is 
not an unexpected finding as the severity of the anaemia in canine babesiosis is seldom 
proportional to the magnitude of the peripheral parasitaemia and additional mechanisms, such 
as oxidative and immune-mediated injury to erythrocytes, are suspected to contribute to 
erythrocyte loss (Otsuka et al., 2002; Irwin, 2010; Scheepers et al., 2011). 
Intermittent leucopenia and neutropenia were noted in both infected dogs throughout 
the experiment. Although neutropenia has previously been documented in B. gibsoni 
infections, the aetiology remains unknown. Sequestration, increased utilisation and reduced 
production are postulated as potential causes (Meinkoth et al., 2002; Matijatko et al., 2007). 
Both infected dogs in this experiment became profoundly, albeit transiently, 
thrombocytopenic. In contrast to the anaemia, thromb cytopenia developed prior to the onset 
of peripheral parasitaemia but, like the anaemia, also resolved despite further increases in the 
magnitude of the peripheral parasitaemia. Thrombocytopenia is one of the most consistent 
haematological features of canine babesiosis (Kettner et al., 2003; Matijatko et al., 2007). It is 
generally considered to be an immune-mediated phenom n, although consumption and 
sequestration of platelets may also play a role (Jefferi s et al., 2007b). Interestingly, neither 
infected dog developed any clinical evidence of haemorrhagic diatheses despite the presence 














pertaining to canine babesiosis where severe thrombocytopenia without apparent clinical 
effect is frequently reported (Kettner et al., 2003; Jefferies et al., 2007b).  
Both infected dogs demonstrated a marked acute phase response to experimental B. 
gibsoni infection. A mild, transient increase in the concentration of CRP was noted in both 
infected dogs on Day 3. C-reactive protein concentrations then returned to within reference 
intervals until Day 13 when a more marked increase occurred, which peaked on Day 15 
coincident with the onset of peripheral parasitaemia. Following this the concentration of CRP 
gradually decreased despite further increases in the magnitude of the peripheral parasitaemia, 
but remained mildly elevated in both infected dogs for the remainder of the experiment. As a 
major acute phase protein in dogs the concentration of CRP typically increases rapidly after 
infection. However, the timing of the acute phase response can be affected by the nature and 
dose of inoculum received (Ceron et al., 2005). Six month old beagle puppies experimentally 
infected with 102, 104 or 106 B. canis infected erythrocytes all developed marked increases in 
the concentration of CRP within 2-4 days of infection regardless of the dose of inoculum 
received and these increases were sustained in all dogs throughout the duration of the two 
week long experiment (Schetters et al., 2009). Thisdemonstrates the marked difference in the 
timing of the acute phase response induced by different species of babesial parasite and 
indicates that the peak of the acute phase response induced by experimental B. gibsoni 
infection may be delayed by as much as two weeks following infection. 
Increased concentrations of CRP have also previously been documented in dogs 
naturally infected with B. rossi and B. canis at the time of presentation to a veterinary hospital 
with clinical signs of canine babesiosis (Ulutas et al., 2005; Matijatko et al., 2007; Koster et 
al., 2009). However, these dogs were all parasitaemic at the time that increased concentrations 














gibsoni infection preceded the detection of peripheral parasitaemia. Increased concentrations 
of CRP were also noted in beagle puppies experimentally infected with B. canis prior to the 
detection of peripheral parasitaemia (Schetters et al., 2009). This is of clinical significance, as 
dogs infected with babesial organisms could potentially present with clinical signs of canine 
babesiosis without a detectable parasitaemia and the absence of a peripheral parasitaemia in a 
sick dog should not exclude a diagnosis of babesiosis. 
Increased concentrations of multiple cytokines were det cted in both infected dogs in 
this study. However, these increases were delayed b more than two weeks following 
infection and did not develop until after a peripheral parasitaemia was detected. Cytokines are 
fundamentally involved in the pathophysiology of the systemic inflammatory response to 
infection (Borghetti et al., 2009; Lewis et al., 201 ). The interval between experimental B. 
gibsoni infection and the cytokine alterations detected in th s study indicates that the systemic 
inflammatory response induced by experimental B. gibsoni infection, like the acute phase 
response, may be delayed by more than two weeks following infection. 
In this study the acute phase response preceded the cytokine alterations. This is 
surprising given that inflammatory cytokines, particularly TNF-α and IL-6, are reported to be 
responsible for stimulating the acute phase response. This may reflect transient increases in 
the concentration of cytokines which were not detect d by the intermittent measurement of 
cytokine concentrations in this experiment; biologically significant increases in the 
concentration of cytokines that were below the limit of detection of the assay used in this 
experiment; local production and release of cytokines within organ systems which were not 
reflected in the systemic concentration of cytokines; or that other mechanisms were involved 
in triggering the acute phase response. 














onwards in Dog 1 and on Day 23 in Dog 2. Concentrations of TNF-α have previously been 
evaluated in a cross-sectional study of dogs at the tim  of presentation to a veterinary hospital 
with clinical signs of canine babesiosis following atural B. rossi infection (Vaughan-Scott, 
2001). Higher TNF-α concentrations were documented in dogs with higher peripheral 
parasitaemia and more severe disease but no association between TNF-α concentration and 
mortality was identified. Tumour necrosis factor alpha is a potent pleiotropic inflammatory 
cytokine responsible for inducing the production of multiple other cytokines and mediating 
many of the physiological disturbances characteristic of sepsis (Blackwell and Christman, 
1996). Interleukin-6 is a multifunctional immunoregulatory cytokine which plays a crucial 
role in B and T cell activation and the induction of the acute phase response (Scheller et al., 
2011). Together, TNF-α and IL-6 drive the initial inflammatory response to infection and 
have been implicated as playing a pivotal role in the pathophysiology of sepsis. Increased 
concentrations of both TNF-α and IL-6 have been correlated with increasing disease severity 
and mortality rates in septic dogs (Otto et al., 1997; Rau et al., 2007; Lewis et al., 2012). 
Given the importance of these cytokines in systemic inflammatory states it is highly likely 
that they also play an important role in the immunopathogenesis of canine babesiosis. 
Increased concentrations of multiple other cytokines including GM-CSF, IL-2, IL-7, 
IL-10, IL-15, IL-18 and KC-like were noted in both infected dogs in this study while the 
concentration of IL-8 increased only in Dog 2. All cytokines exhibit a degree of pleiotropy 
and redundancy with multiple overlapping actions (Akdis et al., 2011). Interleukins 2, 7 and 
15 are all members of the IL-2 cytokine family and all play a role in B and T cell growth, 
differentiation and activation (Akdis et al., 2011). Likewise, IL-18, a member of the IL-1 
cytokine family, also plays a role in T cell development (Akdis et al., 2011). In contrast, IL-8 














important anti-inflammatory cytokine that regulates he immune response by inhibiting T cell 
activation and the production of pro-inflammatory cytokines (Akdis et al., 2011). The role of 
these cytokines in systemic inflammatory states in dogs is currently poorly understood. 
While the concentrations of multiple cytokines were documented to increase 
simultaneously in an infected dog, the timing of these alterations was often different between 
dogs. We suggest that this reflects differences in individual host’s immune response to 
infection. Even though the beagles used in this experiment were litter-mates and managed 
under identical environmental conditions, differencs in genes and their regulatory elements 
likely existed between dogs, which may explain the different cytokine profiles seen. Further 
characterisation of the different cytokine profiles seen in infectious diseases may help 
delineate different patterns of immunological response which are associated with distinct 
clinical presentations and outcomes and allow the ident fication of specific diagnostic markers 
and future therapeutic interventions. 
Other cytokines, such as IFN-γ and IP-10, that did not increase above the minimum 
detectable concentration at any time in either infected or control dogs are considered unlikely 
to play an important role in the immunopathogenesis of canine babesiosis. This is not a 
surprising finding given that the predominant role f IFN-γ is in the inhibition of viral 
infections and the production of IP-10 is induced by IFN-γ. 
This study has a number of limitations. Due to ethical considerations only a small 
number of dogs were able to be used in the experiment. This precluded any statistical analysis 
of the results from being performed. The young age of the beagles used in the experiment 
makes it difficult to directly compare the immune responses of the dogs in the study to those 
of adult dogs, as dogs are generally not considered fully immunocompetent until 12 months of 














of circulating B and T lymphocyte subpopulations in puppies has been documented to be the 
same as those in adult dogs (Felsburg, 2002). Additionally, following the decline in maternal 
immunoglobulins in puppies, normal adult concentrations of serum IgM and IgG can be 
reached by as early as two and six months of age respectively (Felsburg, 2002). Thus it is 
possible that the dogs used in this study were immunocompetent, but interpretation of the 
immune response of the dogs in this study as equivalent to those of adult dogs must be done 
with caution. 
The experimental model used in this study may not accurately reflect what occurs 
during a naturally-acquired B. gibsoni infection. An intravenous route of inoculation is 
different to that of a naturally acquired tick-based infection, but is not dissimilar to an 
infection acquired via blood transmission during a fight. However, the number of parasites 
passaged into the dogs in this study was likely much higher than would occur in a naturally 
acquired infection from either a tick bite or blood exchange during a fight. These factors 
could impact the resultant immune response, cytokine alterations and acute phase response 
seen in the dogs in this experiment although to date no studies have been conducted 
evaluating the effect of the dose or route of inoculum on the cytokine kinetics in canine 
babesial infections. The relatively limited duration f the study also restricted our 
understanding of the clinical, haematological, cytokine and acute phase protein changes that 
occur during experimental B. gibsoni infection of beagle puppies to the initial phase of 
infection only. Finally, as the range of cytokines measured in this experiment was 
predetermined by assay availability, some biologically important cytokines may not have 

















Experimental B. gibsoni infection of beagle puppies is characterised by the 
development of a transient pyrexia and anaemia, intermi tent neutropenia and a profound, but 
likewise transient thrombocytopenia without apparent cli ical effect. Experimental B. gibsoni 
infection of beagle puppies induces an acute phase response, characterised by a marked 
increase in the concentration of CRP, which is delayed in onset by some weeks following 
infection but precedes the detection of peripheral parasitaemia. Experimental B. gibsoni 
infection of beagle puppies is also associated withmarked increases in the concentration of 
multiple cytokines. However, these cytokine alterations were delayed in onset by more than 
two weeks following infection and occurred subsequent to the detection of peripheral 
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Fig.1. Peripheral parasitaemia (expressed as the perc ntage of the total number of red blood 
























Fig.2. Red blood cell count of infected (Dogs 1 and2) and control (Dogs 3 and 4) dogs during 
experimental B. gibsoni infection. Based on age and breed specific referenc  intervals 
previously described for laboratory beagles dogs were considered anaemic when the absolute 
red blood cell count was less than 3.7 x 1012/L (Harper et al., 2003). The arrow indicates the 






















Fig.3. Neutrophil count of infected (Dogs 1 and 2) and control (Dogs 3 and 4) dogs during 
experimental B. gibsoni infection. Dogs were considered neutropenic when t absolute 
neutrophil count was less than 3.0 x 109/L. The arrow indicates the day that peripheral 























Fig.4. Absolute platelet count of infected (Dogs 1 and 2) and control (Dogs 3 and 4) dogs 
during experimental B. gibsoni infection. Dogs were considered thrombocytopenic when the 
platelet count was less than 150 x 109/L unless manual smear assessment revealed sufficient 
platelet clumping that platelet numbers were deemed adequate. The arrow indicates the day 






















Fig.5. CRP concentration of infected (Dogs 1 and 2) and control (Dogs 3 and 4) dogs during 
experimental B. gibsoni infection. Based on age and breed specific referenc  intervals 
previously described for laboratory beagles the concentration of CRP was considered 
increased when it was greater than 15mg/L (Kuribayashi et al., 2003). The arrow indicates the 






















Fig.6. TNF-α concentration of infected (Dogs 1 and 2) and control (Dogs 3 and 4) dogs during 

























Fig.7. MCP-1 concentration of infected (Dogs 1 and 2) and control (Dogs 3 and 4) dogs 























Fig.8. GM-CSF concentration of infected (Dogs 1 and2) and control (Dogs 3 and 4) dogs 
























Fig.9. IL-2 concentration of infected (Dogs 1 and 2) and control (Dogs 3 and 4) dogs during 

























Fig.10. IL-6 concentration of infected (Dogs 1 and 2) and control (Dogs 3 and 4) dogs during 























Fig.11. IL-7 concentration of infected (Dogs 1 and 2) and control (Dogs 3 and 4) dogs during 
























Fig.12. IL-8 concentration of infected (Dogs 1 and 2) and control (Dogs 3 and 4) dogs during 

























Fig.13. IL-10 concentration of infected (Dogs 1 and 2) and control (Dogs 3 and 4) dogs 

























Fig.14. IL-15 concentration of infected (Dogs 1 and 2) and control (Dogs 3 and 4) dogs 






















Fig.15. IL-18 concentration of infected (Dogs 1 and 2) and control (Dogs 3 and 4) dogs 
























Fig.16. KC-like concentration of infected (Dogs 1 and 2) and control (Dogs 3 and 4) dogs 

























• Experimental B. gibsoni infection caused transient pyrexia and anaemia. 
• Infection induced a transient thrombocytopenia without apparent clinical effect. 
• The acute phase response was marked but delayed and preceded parasitaemia. 
• B. gibsoni infection induced marked but delayed increases in multiple cytokines. 
• Cytokine alterations occurred following the acute phase response and parasitaemia.  
 
 
